ZenOnco, an Integrative Oncology healthtech platform, has raised US $1.4 mn in seed funding. The round was led by Enzia Ventures, with participation from Better Capital, Apollo Hospitals, Titan Capital, Dr Arvind Kumar and several long-term associated angel investors looking to make an impact in the cancer care domain. In this round, the founders have also subscribed to additional equity of Rs 1 crore. The funds will be invested to scale-up ZenOnco.io’s existing operations and launch new products to make Integrative Oncology accessible and affordable for all.

ZenOnco.io has been founded by the founders of NGO Love Heals Cancer. The two founders, Dimple Parmar and Kishan Shah.  ZenOnco.io and Love Heals Cancer provide personalized end-to-end cancer care to patients free of cost in their treatment journey. This includes medical treatment, multi-disciplinary tumour board, diagnostic tests, affordable chemo drugs, managing treatment side effects, anti-cancer diet, emotional wellness, palliative care and end-of-life care. ZenOnco.io provides 360-degree care to cancer patients through its in-house team of dedicated doctors available 24/7 to guide cancer patients in their treatment journey. ZenOnco.io has also created India’s first cancer community App dedicated to connect patients with cancer survivors, caregivers and patients.

Dimple Parmar and Kishan Shah, Founders of ZenOnco.io and Love Heals Cancer, say, “We are happy to find like-minded investors who want to make a long-term impact in the field of cancer care. This investment allows us to reach out to more people, launch new products, and make personalized cancer care more accessible and affordable. We can definitely save lives by working together.”